ASX - By Stock
|
4DX |
Re:
The AGM thoughts...
|
|
Hitman19
|
13 |
5.5K |
7 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
5.5K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
The AGM thoughts...
|
|
Hitman19
|
13 |
5.5K |
2 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
5.5K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
The AGM thoughts...
|
|
Hitman19
|
13 |
5.5K |
1 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
5.5K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
The AGM thoughts...
|
|
Hitman19
|
13 |
5.5K |
17 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
13
|
5.5K
|
17
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
2 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
Hitman19
|
43 |
17K |
3 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
43
|
17K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical progresses towards full reimbursement in the US
|
|
Hitman19
|
16 |
8.6K |
5 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
16
|
8.6K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
1 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
2 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Hitman19
|
1 |
717 |
1 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
1
|
717
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
1 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
4 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
7 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
7 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
6 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
3 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Hitman19
|
51 |
19K |
2 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
51
|
19K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Hitman19
|
51 |
19K |
9 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
51
|
19K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Hitman19
|
51 |
19K |
5 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
51
|
19K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
5 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
3 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Hitman19
|
51 |
19K |
4 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
51
|
19K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
6 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
4 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
6 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Andreas Latest Interview
|
|
Hitman19
|
9 |
4.0K |
1 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
9
|
4.0K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
7 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
Hitman19
|
53 |
23K |
5 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
53
|
23K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
Hitman19
|
58 |
25K |
2 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
58
|
25K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
Hitman19
|
58 |
25K |
0 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
58
|
25K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
Hitman19
|
58 |
25K |
12 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
58
|
25K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical clinical trial results presented at ATS
|
|
Hitman19
|
64 |
31K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
64
|
31K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical clinical trial results presented at ATS
|
|
Hitman19
|
64 |
31K |
7 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
64
|
31K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical clinical trial results presented at ATS
|
|
Hitman19
|
64 |
31K |
5 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
64
|
31K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical clinical trial results presented at ATS
|
|
Hitman19
|
64 |
31K |
1 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
64
|
31K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
8 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
7 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX purpose-built 4D lung scanner for its XV Technology
|
|
Hitman19
|
19 |
12K |
8 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
19
|
12K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Appointment and resignation of Company Secretary
|
|
Hitman19
|
10 |
4.1K |
5 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
10
|
4.1K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
1 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
4 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
2 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
1 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
2 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
6 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
3 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Hitman19
|
2.5K |
1.1M |
6 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Completion of first commercial scans at I-MED
|
|
Hitman19
|
34 |
9.9K |
0 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
34
|
9.9K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Completion of first commercial scans at I-MED
|
|
Hitman19
|
34 |
9.9K |
4 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
34
|
9.9K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Completion of first commercial scans at I-MED
|
|
Hitman19
|
34 |
9.9K |
3 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
34
|
9.9K
|
3
|
|